Amgen Builds Holly Springs, North Carolina, Biologics Manufacturing Center
08/04/2021
The company’s new site in the Research Triangle area of North Carolina will bring a biologics drug substance manufacturing plant online to help the company continue to meet the production demands for its life-saving medicines.
“Amgen is investing in a technologically-advanced drug substance plant in North Carolina to support the expected increase in demand for our medicines. Together with the previously announced advanced packaging plant in Ohio, we have committed to investing nearly $1 billion in new manufacturing capacity in the United States,” said Amgen Executive Vice President of Operations Esteban Santos.
Amgen’s project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state’s Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, economists in the Department of Commerce estimate the project will grow the state’s economy by $2.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $11,612,250, spread over 12 years, based on a required capital investment of $380.5 million. Over those 12 years, new state tax revenues generated by the new jobs will exceed $63.6 million.
State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant’s reimbursement payments to a given company.
"World-class companies like Amgen are very selective when they evaluate business locations and they only choose places that provide the best support for their operations,” said Governor Roy Cooper. “Today’s decision proves once again that North Carolina remains a premier location for the most innovative biotech companies in the industry.”
Amgen’s JDIG agreement could also move as much as $3,870,750 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 3 county such as Wake, their JDIG agreements move some of the new tax revenue into the state’s Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community’s ability to attract companies to their regions.
“It’s exciting to see the industry where I spent much of my career become such a vital economic engine for our state,” said North Carolina Commerce Secretary Machelle Baker Sanders. “As the state’s new First in Talent strategic plan makes clear, developing and maintaining a skilled and diverse workforce will lead to more economic growth and great decisions like Amgen’s choice today.”
The Amgen facility in North Carolina will be built to exacting environmental standards, consistent with the company’s goal of achieving carbon neutrality, reducing water use by 40% and waste disposal by 75% by 2027. The facility also will support Amgen’s participation as a founding member of OneTen, a coalition of many of the world’s largest, best-known companies that aims collectively to hire one million Black Americans into well-paying jobs over the next ten years, with a specific focus on those without a four-year college degree.
Project Announcements
Zekelman Industries Expands Blytheville, Arkansas, Operations
04/19/2024
Fibrebond Corporation Expands Webster Parish, Louisiana, Operations
04/19/2024
Master Steel Expands Hardeeville, South Carolina, Operations
04/19/2024
L3Harris Technologies Expands Orange County, Virginia, Operations
04/18/2024
Republic Airways Holdings Plans Tuskegee, Alabama, Training Operations
04/18/2024
South Africa-Based Radel Plans Winston-Salem, North Carolina, Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024